Purevax Rabies
Active substance
ATC code
Species
Cats.
Indications
Active immunisation of cats 12 weeks of age and older to prevent mortality due to rabies infection.
Onset of immunity: 4 weeks after the primary vaccination course.
Duration of immunity after primary vaccination: 1 year.
Duration of immunity after revaccination: 3 years.
Dose to be administered and administration route
Subcutaneous use.
Apply usual aseptic procedures.
Administer one dose of 1 ml according to the following vaccination scheme:
| Primary vaccination: | 1 injection from 12 weeks of age. |
| Revaccination: | 1 year after primary vaccination, then at intervals of up to 3 years. |
Travel to countries requiring a rabies serology test: experience has shown that some vaccinated animals, while protected, may not show the 0.5 IU/ml antibody titre required by some countries. Veterinary surgeons may wish to consider two vaccinations. The best time for a blood sample to be taken is around 28 days after vaccination.
Adverse reactions
Cats:
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Apathy1-2, mild anorexia2, hyperthermia2-3 Injection site reactions (pain, swelling, warmth and erythema)4 |
1 Slight
2 Usually lasting 1 or 2 days. Most of these reactions were noted during the 2 days following the vaccine injection.
3 Above 39.5°C
4 Pain at palpation; limited swelling that may become nodular; usually disappearing within 1 or 2 weeks at most.
5 Which may require appropriate symptomatic treatment
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also section “Contact details” of the package leaflet.
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 04491/5051 |
| EAN | 3661103039303 |
